latest news releases from the newsroom
Lake City Bank
Lake City Bank Reports 2nd Quarter Results
WARSAW, Ind., July 27, 2009 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq:LKFN), parent company of Lake City Bank, today reported net income of $4.5 million for the second quarter of 2009 versus $4.8 million for the second quarter of 2008. Diluted net income per share for the quarter was $0.29 versus $0.39 for the comparable period of 2008. On a linked quarter basis, these results compared to net income of $3.9 million, or $0.29 per diluted share, for the first quarter of 2009.
AERT, Inc. Second Quarter Conference Call
SPRINGDALE, Ark., July 27, 2009 (GLOBE NEWSWIRE) -- Advanced Environmental Recycling Technologies, Inc. (Nasdaq:AERT), a leading plastics recycler and leading manufacturer of Green building products, today announced it will hold a conference call to discuss the company's 2009 second quarter results on Tuesday, July 28, at 3:00 PM CDT/4:00 PM Eastern time.
Chemical Financial Corporation
Chemical Financial Corporation Reports Second Quarter 2009 Earnings
MIDLAND, Mich., July 27, 2009 (GLOBE NEWSWIRE) -- Chemical Financial Corporation (Nasdaq:CHFC) today announced 2009 second quarter net income of $2.3 million, or $0.10 per diluted share, versus net income of $9.6 million, or $0.40 per diluted share, in the second quarter of 2008.
Integrity Media: A Deeper Look By a Market Expert
LAS VEGAS, July 27, 2009 (GLOBE NEWSWIRE) -- Reliable voices in the stock market are uncommon of late with many of the loudest pundits battered by the Year That Was 2008. But a few stalwart figures have emerged, emboldened by their survival skills and much sought after in this bull-like market.
Ceragenix and Megapharm Enter Into Distribution and Supply Agreement for EpiCeram(R)
DENVER, Jul 27, 2009 -- Ceragenix Pharmaceuticals, Inc.("Ceragenix"), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive distribution and supply agreement (the "Agreement") with Megapharm Ltd., an Israeli company, ("Megapharm"), to commercialize EpiCeram(R), a topical cream for treating atopic dermatitis and other dry skin conditions in Israel and the Palestinian territories (the "Territory"). The Agreement grants Megapharm exclusivity in the Territory for the distribution and marketing of EpiCeram(R) while Ceragenix will be responsible for the manufacturing and supply of the product. Megapharm is also responsible for obtaining regulatory clearance to market EpiCeram(R) in the Territory. Financial terms were not disclosed.